All In Biotech

Drug Trial Radar · NCT05518123

Efficacy and Tolerability of Rimegepant for the Prevention of Migraine in Adults With History of Inadequate Response to Oral Preventive Medications

A Phase 4, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Tolerability of Rimegepant for the Prevention of Migraine in Adults With a History of Inadequate Response to Oral Preventive Medications

Last checked: Nov 20, 2026Latest source record: May 22, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 962 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

962

Actual

Start

Nov 7, 2022

Primary completion

Mar 31, 2025

Study completion Jul 8, 2025

Sponsor

Lead sponsor
PfizerPfizer (PFE)
Sponsor type
Industry
First posted
Aug 26, 2022

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Prevention
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study is being conducted to evaluate the efficacy and tolerability of rimegepant for migraine prophylaxis in adults with a history of inadequate response to oral preventive medications

Conditions

  • Migraine

Interventions

  • RimegepantDrug

    Rimegepant 75 mg Oral Disintegrating Tablet (ODT) taken every other day during Double-blind Treatment (DBT) phase

  • PlaceboDrug

    Matching placebo with every other day dosing during DBT phase

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Mean Change From Observation Phase (OP) in the Number of Migraine Days Per Month Over the Entire DBT Phase (Weeks 1 to 12)Time frame: Observation phase (28 days prior to randomization), DBT phase (through Month 3 [Week 1 to 12])

Locations

111 sites in 14 countries. Site status is shown where the registry gives one.

  • Clinical Research Institute

    Los Angeles, California

  • California Neuroscience Research, LLC

    Sherman Oaks, California

  • Ki Health Partners LLC, dba New England Institute for Clinical Research

    Stamford, Connecticut

  • Sandhill Research, LLC d/b/a Accel Research Sites Network-Edgewater Clinical Research Unit

    Edgewater, Florida

  • Wr-Msra,Llc

    Lake City, Florida

  • AppleMed Research Group, LLC

    Miami, Florida

  • Sensible Healthcare LLC

    Ocoee, Florida

  • Sandhill Research, LLC d/b/a Accel Research Sites Network - Ormond Clinical Research Unit

    Ormond Beach, Florida

  • Boston Clinical Trials

    Boston, Massachusetts

  • Community Clinical Research Network, Inc.

    Marlborough, Massachusetts

  • Michigan Headache & Neurological Institute

    Ann Arbor, Michigan

  • Rochester Medical Group

    Rochester Hills, Michigan

  • Clinvest Research, LLC

    Springfield, Missouri

  • St Charles Clinical Research

    Weldon Spring, Missouri

  • Wr-Crcn, Llc

    Las Vegas, Nevada

  • Albuquerque Clinical Trials. Inc.

    Albuquerque, New Mexico

  • DiGiovanna Institute for Medical Education And Research

    North Massapequa, New York

  • Headache Wellness Center, PC

    Greensboro, North Carolina

  • Synexus Clinical Research US, Inc. - Anderson

    Anderson, South Carolina

  • Alliance for Multispecialty Reseach, LLC

    Knoxville, Tennessee

  • Red Star Research, LLC

    Lake Jackson, Texas

  • DM Clinical Research

    Tomball, Texas

  • Northwest Clinical Research Center

    Bellevue, Washington

  • USC Clinical Trials Sunshine Coast

    Sippy Downs, Queensland, Australia

  • Klinikum Klagenfurt am Wörthersee

    Klagenfurt, Austria

  • Medical University Innsbruck

    Innsbruck, Tyrol, Austria

  • GZA Ziekenhuizen

    Antwerp, Belgium

  • AZ Sint-Jan Brugge-Oostende AV

    Bruges, Belgium

  • Jessa Ziekenhuis

    Hasselt, Belgium

  • Clinique de la Citadelle

    Liège, Belgium

  • Cabinet Privé Dr. Simona Sava

    Saint Nicolas Province de Liège, Belgium

  • UZ Brussel

    Jette, Brussels Capital, Belgium

  • ALPHA Recherche Clinique

    Québec, Canada

  • Aggarwal and Associates Limited

    Brampton, Ontario, Canada

  • NeuPath Centre for Pain and Spine

    Brampton, Ontario, Canada

  • Centre de Recherche Saint-Louis/Clinique Neuro-Levis

    Lévis, Quebec, Canada

  • ALPHA Recherche Clinique

    Québec, Quebec, Canada

  • University Hospital of Southern Denmark

    Esbjerg, Denmark

  • Hospitalsenhed Midt

    Viborg, Denmark

  • Bispebjerg Hospital

    Copenhagen NV, Capital Region, Denmark

Showing 40 of 111 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.